US 12194078
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
granted A61KA61K2300/00A61K31/165
Quick answer
US patent 12194078 (Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant) held by Cartesian Therapeutics, Inc. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cartesian Therapeutics, Inc.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2300/00, A61K31/165, A61K31/192, A61K31/436